• Colorectal Cancer Info MAIN MENU
  • Screen MAIN MENU
  • Care MAIN MENU
  • Cure MAIN MENU
  • Get Involved MAIN MENU
  • Our Mission MAIN MENU

Subscribe to the Newsletter

What is the KRAS biomarker?


The KRAS gene is responsible for the production of the K-Ras protein. The protein acts as an “on-off” switch that instructs cells to grow and divide or mature and take on different functions. The KRAS gene is an oncogene because when it is mutated or changed it can cause normal cells to become cancerous. KRAS is a member of the RAS family of genes that include NRAS and HRAS. These are important in cell growth, formation of cancer, and cell destruction (apoptosis). K-Ras is an important part of the RAS/MAPK pathway. There are several drugs being investigated that work on different components of the pathway.

What does KRAS mutation mean?


When and how should I have a KRAS biomarker test?


Experts recommend that anyone with stage IV or metastatic colorectal cancer (mCRC) should be tested for multiple genetic (genomic) mutations including KRAS and NRAS. RAS status must be determined prior to the start of any EGFR-inhibitors. Biomarker testing should be done on the primary tumor and any subsequent metastases with comprehensive genomic testing.

What do I do with this information?


Knowing the details of tumor biomarkers can help you and your doctor make decisions about personalized treatment with therapies tailored specifically to the characteristics of your tumor.

  • A mutation in the KRAS gene is a predictive biomarker for a poor response to EGFR-inhibitors. Therefore, patients with a KRAS mutation or unknown KRAS status should not receive EGFR-inhibitors like Cetuximab or Panitumumab alone or in combination with chemotherapy.
  • Patients with mutated or unknown KRAS or NRAS status should receive chemotherapy including FOLFOX, CAPOX, or FOLFIRI with or without Bevacizumab (an antibody that inhibits the growth of blood vessels and oxygen supply in the tumor).

Currently, there are no specific anti-KRAS therapies but there are ongoing clinical trials looking at potential KRAS inhibitors.

What are the potential side effects ?


Every treatment has the potential to cause some side effects. Some people may be more sensitive than others to a particular drug. The response to a specific treatment also depends on your other treatments (for example, radiation) and medications. It may also depend on vitamins and herbal supplements. Tell your doctor and pharmacist about all of your medications, vitamins, and treatments. If you are experiencing severe side effects, call your doctor immediately.

For more on side effects of other chemotherapy regimens, click here.


Download: The KRAS Biomarker

Learn about the KRAS Biomarker.

Download English

Latest Updates

Upcoming Events

Are you sure?

Clicking "Start Over" will empty your resources drawer and take you back to the beginning of the journey customizer. Would you like to continue?

Are you sure?

Clicking "Exit" will permanently close your resource drawer for the rest of the session. If you would like to minimize the drawer and access it from other pages, click the symbol next to "MY RESOURCES". Would you like to permanently exit the drawer?